Back to Results
First PageMeta Content
Medicine / Clinical medicine / Immunology / Immune system / T cells / Cancer treatments / Tumor / Programmed cell death protein 1 / Tumor microenvironment / T helper cell / Cancer immunotherapy / Interleukin 10


Safety, immune activation and anti-tumor efficacy of PEGylated recombinant human IL-10 (AM0010) Jeffrey R. Infante, MD AACR 2016 Aung Naing1, Kyriakos P. Papadopoulos2, Karen A. Autio3, Patrick A. Ott4, Manish Patel5, De
Add to Reading List

Document Date: 2016-06-22 11:57:33


Open Document

File Size: 2,55 MB

Share Result on Facebook